Rectal Adenocarcinoma

Showing NaN - NaN of 4

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Colon Adenocarcinoma, ERBB2 Gene Amplification, Rectal Adenocarcinoma Trial in Puerto Rico, United States (biological, drug,

Active, not recruiting
  • Colon Adenocarcinoma
  • +18 more
  • Cetuximab
  • +5 more
  • Anchorage, Alaska
  • +797 more
Jan 9, 2023

Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v7, Stage III Rectal Cancer AJCC v7 Trial in Puerto Rico, United States

Active, not recruiting
  • Rectal Adenocarcinoma
  • +2 more
  • Birmingham, Alabama
  • +649 more
Aug 5, 2022

Colon Adenocarcinoma, Rectal Adenocarcinoma, Stage III Colorectal Cancer AJCC v7 Trial in United States (Clobetasol Propionate,

Active, not recruiting
  • Colon Adenocarcinoma
  • +8 more
  • Clobetasol Propionate
  • +3 more
  • Phoenix, Arizona
  • +21 more
Jan 5, 2022

Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v7, Stage III Rectal Cancer AJCC v7 Trial in United States (biological, drug,

Completed
  • Rectal Adenocarcinoma
  • +2 more
  • Bevacizumab
  • +6 more
  • Birmingham, Alabama
  • +106 more
Mar 13, 2019